Browse > Article
http://dx.doi.org/10.5352/JLS.2009.19.6.770

The Anticancer Effect and Mechanism of Photodynamic Therapy Using 9-Hydroxypheophorbide-a and 660 nm Diode Laser on Human Squamous Carcinoma Cell Line.  

Ahn, Jin-Chul (Medical Laser and Device Research Center, Dankook University)
Publication Information
Journal of Life Science / v.19, no.6, 2009 , pp. 770-780 More about this Journal
Abstract
A new photosensitizer, 9-Hydroxypheophorbide-a (9-HpbD-a), was derived from Spirulina platensis. We conducted a series of experiments, in vitro and in vivo, to evaluate the anticancer effect and mechanism of photodynamic therapy using 9-HpbD-a and 660 nm diode lasers on a squamous carcinoma cell line. We studied the cytotoxic effects of pheophytin-a, 9-HpbD-a, 9-HpbD-a red and 660 nm diode lasers in a human head and neck cancer cell line (SNU-1041). Cell growth inhibition was determined by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. The effects of 9-HpbD was higher than those of 9-HpbD-a red or pheophytin-a in PDT. We then tested the cytotoxic effects of 9-hydroxypheophorbide-a (9-HpbD-a) in vitro. The cultured SNU-I041 cells were treated with serial concentrations of 9-HpbD-a followed by various energy doses (0, 0.1, 0.5, 3.2 J/$cm^{2}$) and by various interval times (0, 3, 6, 9, 12 hr) until laser irradiation, then MTT assay was applied to measure the relative inhibitory effects of photodynamic therapy (PDT). Optimal laser irradiation time was 30 minutes and the cytotoxic effects according to incubation time after 9-HpbD-a treatment increased until 6 hours, after which it then showed no increase. To observe the cell death mechanism after PDT, SUN-I041 cells were stained by Hoechst 33342 and propidium iodide after PDT, and observed under transmission electron microscopy (TEM). The principal mechanism of PDT at a low dose of 9-HpbD-a was apoptosis, and at a high dose of 9-HpbD-a it was necrosis. PDT effects were also observed in a xenografted nude mouse model. Group I (no 9-HpbD-a, no laser irradiation) and Group II (9-HpbD-a injection only) showed no response (4/4, 100%), and Group III (laser irradiation only) showed recurrence (1/4,25%) or no response (3/4, 75 %). Group IV (9-HpbD-a + laser irradiation) showed complete response (10/16, 62.5%), recurrence (4/16, 25%) or no response (2/16, 12.5%). Group IV showed a significant remission rate compared to other groups (p<0.05). These results suggest that 9-HpbD-a is a promising photosensitizer for the future and that further studies on biodistribution, toxicity and mechanism of action would be needed to use 9-HpbD-a as a photosensitizer in the clinical setting.
Keywords
Photodynamic therapy; photosensitizer; 9-Hydroxypheophorbide-a; cell death mechanism; apoptosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Moan, J., and K. Berg. 1991. The photodegradation of porphrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53, 549-553   DOI   ScienceOn
2 Moor, A. 2000. Signaling pathway in celll death and survival after photodynamic therapy. Photochem. Photobiol. 57, 1-13   DOI   ScienceOn
3 Muller, S., H. Walt, U. Hallr, and D. Fiedler. 1998. Enhanced photodynamic effects using fractinrated laser light. Photochem. Photobiol. 42, 67-70   DOI   ScienceOn
4 Newsholme, E. A., and A. R. Leech. 1984. Biochemistry for the medical sciences. Wiley. New York
5 Noodl, B., T. Berg, O. Sttoke, J. Peng, and J. Nesland. 1996. Apoptosis and necrosis induced with light and 5-ALA derived protoporphyrin IX. Br. J. Cancer. 74, 22-29   DOI   ScienceOn
6 Ochsner, M. 1997. New trends in photobiology (Invited review) Photophysical and photobiological processes in the photodynamic therapy of tumors. Photochem Photobiol. 39, 1-18   DOI
7 Rosenthal, I. 1991. Phthalocyanines as photodynamic sensitizers. Photochem. Photobiol. 53, 859-870   DOI
8 Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833   DOI   ScienceOn
9 McCaughan, L. 1990. Lasers in photodynamic therapy. Nurs. Clin. North Am. 25, 725-738
10 Milanesi, C., C. Zhou, R. Biolo, and G. Jori. 1990. Zn(II)-phthaocyanine as photodynamic agent for tumors. Studies on the mechanism of photosensitized tumor necrosis. Br. J. Cancer. 61, 846-850   DOI   ScienceOn
11 Hampton, J. A., and S. H. Selman. 1992. Mechanism of cell killing in photodynamic therapy using a novel in vivo drug/in vitro light culture system. Photochem. Photobiol. 56, 235-243   DOI   ScienceOn
12 Henderson, B. W., and G. Farrell. 1989. Possible implications of vascular damage for tumor cell inactivation in vivo: vomparison of different photosensitizers. SPIE Cofn. Proc. 1065, 2-10   DOI
13 Hetzell, F. W. and M. Chopp. 1989. Modifications in intratumor microenvironment with PDT. SPIE Conf. Proc. 1065, 41-7   DOI
14 Jin, H., M. F. Horng, T. Deahl, N. L. Oleinick, and H. H. Evans. 1998. Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers. Photochem. Photobiol. 67, 720-728   DOI   ScienceOn
15 Jori, G., E. R. Beltramini, B. Salvato, L. Z. Pagnan, and T. Sanov. 1984. Evidence for a major role of plasma lipoproteins a hematoporphyrin carriers in vivo. Cancer Lett. 24, 291-297   DOI   ScienceOn
16 Kato, H. 1996. History of photodynamic therapy-past, present and future. Gan To Kagaku Ryoho. 23, 8-15
17 Kessel, D., P. Thompson, K. Saaito, and K. D. Nanturri. 1987. Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem. Photobiol. 45, 787-790   DOI   ScienceOn
18 Lee, W. Y., J. H. Park, B. S. Kim, M. J. Han, B. S. Hahn. 1990. Chlorophyll derivatives (CpD) extracted from silk worm excreta are specifically cytotoxic to tumor cells in vitro. Yonsei Med. J. 31, 225-233   DOI
19 McCabe, M., P. Nicotera, and S. Orrenius. 1992. Calcium dependent cell death: role of the endonuclease, protein kinase C and chromatin formation. Ann. NY Acad. Sci. 663, 269-278   DOI
20 Lim, H. W. 1989. Role mediators of inflammationand cells in porphyrin induced phototoxicity. SPIE Conf. Proc. 1065, 28-33   DOI
21 Carl, D. 2000. Update on photodynamic therapy. Curr. Opin. Opthalmol. 11, 166-170   DOI   ScienceOn
22 Crissman, M. J. 1995. Cell cycle analysis by flow cytometry. Cell Growth and apoptosis, 2nd edition. Studzinski, G. P.(ed.). 21-43. IRL press: Oxford
23 Dahle, J., H. B. Steenand, and J. Moan. 1999. The mode of cell death induced by photodynamic treatment depends on cell density. photochemistry and photobiology. 70, 363-367   DOI   ScienceOn
24 Dougherty, T., J. Kaufman, A. Goldfarb, K. Weishaupt and D. Boyle. 1978. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 38, 143-151
25 Fingar, V. H., T. J. Wieman, and K. W. Doak. 1990. The role of thromboxane and prostacyclin release on photodynamic therapy induced tumor destruction. Cancer Res. 50, 2599-2603
26 Foote, C. S. 1987. Type I and Type II mechanisms of photodynamic action, In Heitz, J. R. and K. R Downum (eds.), Light-Activates Pesticides, American Chemical Society, Washington DC. 22-38
27 Fujishima, I., T. Sakai, T. Tanaka, H. Ryu, K. Uemura, Y. Fujishima, K. Horiuchi, N. Daikuzono, Y. Sekiguchi. 1991. Photodynamic therapy using pheophorbide a and Nd:YAG laser. Neurol. Med. Chir. 31, 257-263   DOI
28 Furukawa, K., H. Yamamoto, D. H. Crean, H. Kato, T. S. Man. 1996. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a. Lasers Surg. Med. 18, 157-166   DOI   ScienceOn
29 Gomer, C. J., A. Rucker, and A. Ferrario. 1989. Properties and applications of photodynamic therapy. Radiat. Res. 120, 1-8   DOI   ScienceOn
30 Gibson, S. L., T. L. Checkler, and T. G. Bryant. 1989. Effects of laser photodynamic therapy on tumor phosphate levels and pH assessed by p-NMR spectroscopy. Cancer Biochem. Biophys. 10, 319-328
31 Xiao-Yan, H., A. S. Robert, S. Thomsen, W. K. Leland, and S. L. Jacques. 1994. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell line. Photochem. Photobiol. 59, 468-473   DOI   ScienceOn
32 Berg, K., J. C. Bommer, and J. Moan. 1989. Evaluation of sulphonated aluminum phthalocyanines for use in photochemotherapy. Cellular uptake studies. Cancer Lett. 44, 7-15   DOI   ScienceOn
33 Berg, K. and J. Moan. 1997. Lysosomes and microtubles as targets for photochemotherapy of cancer. Photochem. Photobiol. 65, 403-409   DOI   ScienceOn
34 Specht, K. G., and M. A. Rodgers. 1990. Depolarization of mouse myeloma cell membranes during photodynamic action. Photochem. Photobiol. 51, 319-324   DOI   ScienceOn
35 Tomio, L., G. Redi, P. L. Jori, and G. B. Zorat. 1980. Hematoporphyrin as a sensitizer in tumor phototherapy: effect of medium polarity on the photosensitizing efficiency and role of the administration pathway on the distribution in normal and tumor bearing rats, In Pratesi, R. and C. A. Sacchi (eds.), Lasers in photomedicine and photobiology, Springer-Verlag, Berlin. 76-82
36 Wyld, L., M. W. R. Reed, and N. J. Brown. 2001. Differential cell death response to photodynamic therapy is dependent on dose and cell type. Bri. J. Cancer. 84, 1384-1386   DOI   ScienceOn
37 Zhou, C. 1989. Mechanism of tumor necrosis induced by photodynamic therapy. Photochem. Photobiol. 3, 299-318   DOI   ScienceOn